GHRP-1 alternatives.

10 compounds compared to GHRP-1, ranked by published evidence tier and regulatory status, not by what's marketed hardest.

Why people look for an alternative

GHRP-1 was one of the first growth hormone-releasing peptides out of Cyril Bowers' lab, and its human record never grew past acute GH-response studies. People searching for an alternative are usually reacting to exactly that: they learn it prompts the pituitary through the ghrelin receptor, then find almost nothing published on repeated use, and want something in the same class with more behind it. The honest framing is that the secretagogue class as a whole is thin on approvals. GHRP-2 holds a narrow diagnostic approval in Japan, tesamorelin is FDA-approved for one specific indication, and everything else here sits in the same research-only bracket GHRP-1 occupies.

What you're comparing against
GHRP-1
D tier · 38/100Research / preclinical

GHRP-1 is a synthetic heptapeptide, one of the earliest growth hormone-releasing peptides (GHRPs) developed by Cyril Bowers' group in the 1980s and 1990s alongside GHRP-2 and GHRP-6.

Ranked by evidence · strongest first
  1. 01
    GHRP-2
    D tierResearch / preclinical

    Acts through the ghrelin-receptor agonism pathway, like GHRP-1. Research / preclinical.

  2. 02
    GHRP-6
    D tierResearch / preclinical

    Acts through the ghrelin-receptor agonism pathway, like GHRP-1. Research / preclinical.

  3. 03
    Hexarelin
    D tierResearch / preclinical

    Acts through the ghrelin-receptor agonism pathway, like GHRP-1. Research / preclinical.

  4. 04
    Ipamorelin
    F tierResearch / preclinical

    Acts through the ghrelin-receptor agonism pathway, like GHRP-1. Research / preclinical.

  5. 05
    Human Growth Hormone
    S tierFDA-approved
    HGH · somatropin

    Same category: growth hormone. FDA-approved.

  6. 06
    Tesamorelin
    A tierFDA-approved
    Egrifta

    Same category: growth hormone. FDA-approved.

  7. 07
    Sermorelin
    C tierResearch / preclinical

    Same category: growth hormone. Research / preclinical.

  8. 08
    ACE-031
    D tierIn human trials
    ramatercept · ActRIIB-Fc

    Same category: growth hormone. In human trials.

  9. 09
    CJC-1295
    F tierResearch / preclinical

    Same category: growth hormone. Research / preclinical.

  10. 10
    IGF-1 LR3
    F tierResearch / preclinical

    Same category: growth hormone. Research / preclinical.

How this list is built

An “alternative” here means a compound that shares GHRP-1's mechanism pathway or sits in the same category, not a marketing substitute. Each is ordered by PepCue's evidence tier (a weighted 0–100 score across human data, safety, replication and regulatory clarity), then by whether it's actually approved. This is a research reference, not medical or purchasing advice: an alternative sitting higher on evidence does not mean it's right, safe, or legal for any given use. Reviewed June 1, 2026.

Comparing options with your provider?

PepCue keeps every compound, dose and lab in one private, provider-ready timeline, whichever one you land on.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page
Compounds